Aloxi
What is ALOXI®?
ALOXI® (palonosetron hydrochloride) is a 5-HT3 antagonist.
ALOXI® obtained a centralised registration in Europe in 2005, with an indication for the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy, and the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.
What does ALOXI® do?
Download Product characteristics
Download Patient information leaflet
ALOXI® enquiries
How to order ALOXI®:
|
UK Mawdsleys E-mail: dave.hopkinson@mawdsleys.co.uk |
For any other information relating to ALOXI® please contact:
Telephone: +44 (0) 1244 625152
Email: enquiries@sinclairispharma.com

